EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹21 Cr | ₹19 Cr | ₹9.49 Cr | ₹8.03 Cr | ₹0.08 Cr |
What is the latest Capital Work in Progress ratio of EVEREST ORGANICS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹9.49 Cr |
| Mar2022 | ₹8.03 Cr |
| Mar2021 | ₹0.08 Cr |
How is Capital Work in Progress of EVEREST ORGANICS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 10.46 | |
| Mar2024 | ₹19 Cr | 103.86 | |
| Mar2023 | ₹9.49 Cr | 18.18 | |
| Mar2022 | ₹8.03 Cr | 10,606.67 | |
| Mar2021 | ₹0.08 Cr | - | |
Compare Capital Work in Progress of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹272.6 Cr | -0.5% | -11.3% | -31.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -0.5% |
-11.3% |
-31.1% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses